Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?
Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (54)
- Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training? 2023-03-02 · Expand citations
- Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice. 2023-03-01 · Expand citations
- How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression? 2023-01-01 · Expand citations
- Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy. 2022-05-14 · Expand citations
- Therapeutic use of psilocybin: Practical considerations for dosing and administration. 2022-01-01 · Expand citations
- Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy. 2021-12-01 · Expand citations
- Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice 2021-06-23 · Expand citations
- Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. 2021-01-01 · Expand citations
- The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training 2018-10-05 · Expand citations
- Developing Guidelines and Competencies for the Training of Psychedelic Therapists 2017-06-29 · Expand citations
- Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. 2017-01-01 · Expand citations
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. 2016-12-01 · Expand citations
- Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. 2016-05-01 · Expand citations
- Prediction of psilocybin response in healthy volunteers. 2012-01-01 · Expand citations
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
- Entheogens and Existential Intelligence: The Use of Plant Teachers as Cognitive Tools 2002-01-01 · Expand citations
- OpenAlex W1754961979
- OpenAlex W2014087423
- OpenAlex W2015114767
- OpenAlex W2111459052
- OpenAlex W2113099805
- OpenAlex W2143976056
- OpenAlex W2181847988
- OpenAlex W2316003297
- OpenAlex W2484178742
- OpenAlex W2502147470
- OpenAlex W2767026933
- OpenAlex W2788854095
- OpenAlex W2900604419
- OpenAlex W2965468106
- OpenAlex W3024609058
- OpenAlex W3096897894
- OpenAlex W3114028558
- OpenAlex W3139397908
- OpenAlex W3144810457
- OpenAlex W3157058636
- OpenAlex W3162204693
- OpenAlex W3163974662
- OpenAlex W3210625928
- OpenAlex W356352827
- OpenAlex W4244164154
- OpenAlex W4293080285
- OpenAlex W4366590080
- OpenAlex W4378976526
- OpenAlex W4385495585
- OpenAlex W4386206113
- OpenAlex W4399650907
- OpenAlex W4401417544
- OpenAlex W4401920850
- OpenAlex W4404043063
- OpenAlex W562964222
- OpenAlex W564195063
- OpenAlex W6630948633
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.